AI Age Discrepancy: A Novel Parameter for Frailty Assessment in Kidney Tumor Patients
This addresses frailty assessment for kidney cancer patients to optimize surgical outcomes, but it is incremental as it builds on existing datasets and methods.
This paper tackled the problem of assessing patient frailty in kidney cancer by introducing AI Age Discrepancy, a metric from CT scans, and found that higher values are significantly associated with longer hospital stays and lower survival rates in a study of 599 patients.
Kidney cancer is a global health concern, and accurate assessment of patient frailty is crucial for optimizing surgical outcomes. This paper introduces AI Age Discrepancy, a novel metric derived from machine learning analysis of preoperative abdominal CT scans, as a potential indicator of frailty and postoperative risk in kidney cancer patients. This retrospective study of 599 patients from the 2023 Kidney Tumor Segmentation (KiTS) challenge dataset found that a higher AI Age Discrepancy is significantly associated with longer hospital stays and lower overall survival rates, independent of established factors. This suggests that AI Age Discrepancy may provide valuable insights into patient frailty and could thus inform clinical decision-making in kidney cancer treatment.